Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 07, 2022

SELL
$223.92 - $287.77 $171,074 - $219,856
-764 Closed
0 $0
Q3 2021

Oct 05, 2021

SELL
$282.99 - $369.05 $5,659 - $7,381
-20 Reduced 2.55%
764 $216,000
Q2 2021

Aug 02, 2021

SELL
$259.0 - $414.71 $91,427 - $146,392
-353 Reduced 31.05%
784 $258,000
Q1 2021

Apr 26, 2021

BUY
$242.95 - $284.63 $47,618 - $55,787
196 Added 20.83%
1,137 $318,000
Q4 2020

Jan 12, 2021

SELL
$236.26 - $355.63 $945 - $1,422
-4 Reduced 0.42%
941 $252,000
Q3 2020

Nov 13, 2020

SELL
$264.77 - $305.71 $9,002 - $10,394
-34 Reduced 3.47%
945 $268,000
Q2 2020

Jul 31, 2020

BUY
$258.66 - $342.55 $9,570 - $12,674
37 Added 3.93%
979 $262,000
Q1 2020

May 08, 2020

SELL
$268.85 - $341.04 $1,344 - $1,705
-5 Reduced 0.53%
942 $298,000
Q4 2019

Jan 23, 2020

BUY
$220.06 - $304.07 $17,384 - $24,021
79 Added 9.1%
947 $281,000
Q3 2019

Oct 15, 2019

SELL
$217.44 - $243.88 $11,089 - $12,437
-51 Reduced 5.55%
868 $202,000
Q2 2019

Jul 30, 2019

SELL
$219.29 - $241.72 $15,350 - $16,920
-70 Reduced 7.08%
919 $215,000
Q1 2019

Apr 22, 2019

BUY
$216.71 - $338.96 $214,326 - $335,231
989 New
989 $234,000
Q4 2018

Jan 30, 2019

SELL
$278.5 - $352.75 $183,253 - $232,109
-658 Closed
0 $0
Q3 2018

Oct 10, 2018

BUY
$293.51 - $383.83 $1,467 - $1,919
5 Added 0.77%
658 $227,000
Q2 2018

Aug 22, 2018

BUY
$257.52 - $306.91 $11,073 - $13,197
43 Added 7.05%
653 $190,000
Q1 2018

Apr 24, 2018

BUY
$260.13 - $367.91 $158,679 - $224,425
610 New
610 $167,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.4B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Mc Adam, LLC Portfolio

Follow Mc Adam, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Adam, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Adam, LLC with notifications on news.